R-roscovitine ( DrugBank: R-roscovitine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
75	Cushing disease	2

75. Cushing disease

---

Clinical trials : 205 /  Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03774446 (ClinicalTrials.gov)	November 2, 2018	6/11/2018	Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease	A Phase 2 Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease	Cushing Disease	Drug: Seliciclib	Cedars-Sinai Medical Center	NULL	Active, not recruiting	18 Years	N/A	All	29	Phase 2	United States
2	NCT02160730 (ClinicalTrials.gov)	May 2014	21/5/2014	Treatment of Cushing's Disease With R-roscovitine	Treatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitine	Cushings Disease	Drug: R-roscovitine	Shlomo Melmed, MD	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Terminated	18 Years	N/A	All	4	Phase 2	United States